Table 2.
Summary of Available Data |
Correlates of Lp(a) |
||||
---|---|---|---|---|---|
No. of Studies |
No. of Participants |
Mean (SD) or % |
Pearson Correlation r (95% CI)a |
Percentage Difference (96% CI) in Lp(a) Levels per 1 SD Higher or Compared With Reference Category of Correlateb |
|
Loge Lp(a), mg/dLc | 36 | 126 634 | 2.37 (1.25) | ||
| |||||
Age at survey, y | 36 | 126 634 | 57 (8) | 0.01 (0.00 to 0.02) | 2 (0 to 3) |
| |||||
Sex | 36 | 126 634 | |||
| |||||
Male | 34 | 66 250 | 52 | Reference | |
| |||||
Female | 21 | 60 384 | 48 | 12 (8 to 16) | |
| |||||
Race | 26 | 91 706 | |||
| |||||
White | 26 | 85 046 | 93 | Reference | |
| |||||
Black | 11 | 6223 | 7 | 119 (84 to 161) | |
| |||||
Smoking status | 35 | 122 994 | |||
| |||||
Never/former | 35 | 89 658 | 73 | Reference | |
| |||||
Current | 34 | 33 336 | 27 | 0 (−2 to 3) | |
| |||||
History of diabetes | 36 | 121 027 | |||
| |||||
No | 35 | 113 991 | 94 | Reference | |
| |||||
Yes | 34 | 7036 | 6 | −11 (−17 to −4) | |
| |||||
Systolic blood pressure, mm Hg | 35 | 120 643 | 134 (18) | 0.01 (−0.01 to 0.02) | 1 (0 to 2) |
| |||||
Body mass indexd | 35 | 123 740 | 26 (5) | −0.02 (−0.04 to 0.00) | −4 (−6 to −1) |
| |||||
Lipid markers, mg/dL | |||||
Total cholestrol | 36 | 126 128 | 228 (42) | 0.12 (0.10 to 0.13) | 16 (14 to 18) |
| |||||
HDL-C | 33 | 114889 | 49 (15) | 0.03 (0.02 to 0.04) | 4 (2 to 6) |
| |||||
Non–HDL-C | 33 | 114876 | 178 (42) | 0.11 (0.09 to 0.13) | 14 (12 to 17) |
| |||||
Loge triglyceridesc | 35 | 124 232 | 4.85 (0.51) | −0.05 (−0.07 to −0.02) | −6 (−9 to −3) |
| |||||
Apolipoprotein AI | 21 | 91 480 | 151 (29) | 0.02 (0.00 to 0.04) | 1 (−1 to 4) |
| |||||
Apolipoprotein B | 23 | 93 058 | 108 (28) | 0.11 (0.09 to 0.13) | 15 (11 to 18) |
| |||||
Inflammatory markers | |||||
Loge C-reactive protein, mg/Lc | 27 | 78 153 | 0.62 (1.12) | 0.03 (0.01 to 0.05) | 4 (2 to 6) |
| |||||
Fibrinogen, mg/dL | 25 | 101 346 | 326 (78) | 0.08 (0.06 to 0.10) | 11 (8 to 15) |
SI conversions: To convert total cholesterol, HDL-C, and non-HDL-C to mmol/L, multiply by 0.0259; triglycerides to mmol/L, multiply by 0.0113; apolipoproteins to g/L, multiply by 0.01; C-reactive protein to nmol/L, multiply by 9.524; and fibrinogen to μmol/L, multiply by 0.0294.
Abbreviations: CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; Lp(a), lipoprotein(a).
Pearson correlation coefficients between loge, Lp(a) and the row variables, pooled across studies using random-effects meta-analysis.
Percentage change in Lp(a) levels per 1-SD increase in the variable (or for categorical variables, the percentage difference in mean Lp[a] levels for the category vs the reference), adjusted for age and sex and allowing for random effects across studies.
Median (interquartile range) values were for Lp(a), 12.6 mg/dL (4.9-32.1 mg/dL); triglycerides, 120 mg/dL (86-173 mg/dL); and C-reactive protein, 1.75 mg/L (0.82-3.87 mg/L).
Body mass index is calculated as weight in kilograms divided by height in meters squared.